Challenge
Cerianna (fluoroestradiol F 18) is the first FDA-approved F-18 PET imaging agent specifically indicated for use in patients with recurrent or metastatic breast cancer. With a new product launch on the horizon, Zionexa USA needed a partner to develop its digital presence and educate the market.
Solution
jscTEK developed a custom, fully responsive website for Cerianna that focused on ease of use, branding and physician education. We created the site to allow interpreting physicians to receive on demand training via a portal that leverages an NPI authorization API for verification purposes. Integrated with tracking metrics to monitor and improve site conversions and performance as they grow, the site is also fully compliance with FDA guidelines.
